Newsmeme!
Discover News you didn't know existed
The family checked for a chronic bone disorder
Can early treatment fight a family disease?
Susan Lark, MD, noted medical researcher and women's health practitioner, has spoken out against the newest prescription osteoporosis medication on the market, Reclast, as well as other oral bisphosphonates such as Boniva, Actonel, and Fosamax. (PRWeb Nov 28, 2008) Read the full story at http://www.prweb.com/releases/Dr-Lark/osteoporosis/prweb1672944.htm
Susan Lark, MD, noted medical researcher and women's health practitioner, has spoken out against the newest prescription osteoporosis medication on the market, Reclast, as well as other oral bisphosphonates such as Boniva, Actonel, and Fosamax.
DUBLIN, Ireland - Shares in Merrion Pharmaceuticals plc (DUBLIN:MERR) surged 42 percent Monday on news that the company had secured a licensing deal with Novo Nordisk for the oral delivery of the latter company's proprietary insulin analogues.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |